Listen to expert discussion on identifying adults at risk for reduced HBV seroprotection and applying current HBV vaccine recommendations in special populations.
In this episode, learn about the importance of identifying adults at risk for reduced hepatitis B virus (HBV) seroprotection and applying current HBV vaccine recommendations in special populations. Listen as Robert G. Gish, MD, discusses key information on the identification and evaluation of patients who have chronic health conditions and therefore may be at risk for nonresponse to available vaccines.
Presenter:
Robert G. Gish, MD
Professor of Medicine
Loma Linda University
Loma Linda, California
Adjunct Professor of Medicine
Nevada School of Medicine
Las Vega, Nevada
Clinical Professor
University of Nevada Reno
School of Medicine
Reno, Nevada
Clinical Professor
University of California Skaggs School of
Pharmacy and Pharmaceutical Sciences
San Diego, California
Medical Director
Hepatitis B Foundation
Washington, DC
Review the downloadable slidesets at:
https://bit.ly/3KPiJZz
Link to full program:
https://bit.ly/3OZ50Ta